The AMYPAD Consortium has recently announced the publication of three new papers:
-
“Parametric imaging of dual-time window [18F]flutemetamol and [18F]florbetaben studies”, NeuroImage
-
“Early detection of amyloid load using 18F-florbetaben PET”, Alzheimer's Research & Therapy
-
“White matter microstructure disruption in early stage amyloid pathology”, Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring.
Congratulations to the authors! You can find the papers on the AMYPAD website: https://amypad.eu/resources/publications/
The AMYPAD project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115952. The Joint Undertaking receives support from the European Union’s Horizon2020 research and innovation programme and EFPIA. This article reflects the author’s view and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained herein.
